Nathan Hambly

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.

Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.

Journal: The New England journal of medicine

Published: May 18, 2026

Shining light on a dark prognosis: prognostic factors in pulmonary hypertension associated with interstitial lung disease.

Shining light on a dark prognosis: prognostic factors in pulmonary hypertension associated with interstitial lung disease.

Journal: The European respiratory journal

Published: April 23, 2026

Association of CT Features with Radiologic Patterns in Interstitial Lung Disease: Multinomial Analysis in CARE-PF.

Association of CT Features with Radiologic Patterns in Interstitial Lung Disease: Multinomial Analysis in CARE-PF.

Journal: Radiology

Published: March 17, 2026

Effect of Community Size and Commute Time on Severity of Pulmonary Arterial Hypertension at Diagnosis and Follow-up in Patients Across 3 Sites.

Effect of Community Size and Commute Time on Severity of Pulmonary Arterial Hypertension at Diagnosis and Follow-up in Patients Across 3 Sites.

Journal: CJC open

Published: February 21, 2026

Clinical and Radiologic Characteristics of Familial Pulmonary Fibrosis.

Clinical and Radiologic Characteristics of Familial Pulmonary Fibrosis.

Journal: Annals of the American Thoracic Society

Published: January 14, 2026

Computed tomography-derived pulmonary blood volume distribution may be modifiable in asthma.

Computed tomography-derived pulmonary blood volume distribution may be modifiable in asthma.

Journal: ERJ open research

Published: January 06, 2026

Prevalence, detection, and trajectory of combined pulmonary fibrosis and emphysema.

Prevalence, detection, and trajectory of combined pulmonary fibrosis and emphysema.

Journal: Chest

Published: December 07, 2025

Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study.

Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study.

Journal: Pulmonary circulation

Published: August 24, 2025

Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography.

Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography.

Journal: American journal of respiratory and critical care medicine

Published: June 12, 2025

Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial.

Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: February 06, 2025

CT Honeycombing and Traction Bronchiectasis Extent Independently Predict Survival across Fibrotic Interstitial Lung Disease Subtypes.

CT Honeycombing and Traction Bronchiectasis Extent Independently Predict Survival across Fibrotic Interstitial Lung Disease Subtypes.

Journal: Radiology

Published: February 04, 2025

Impact of reference equations on lung function and outcomes in fibrotic interstitial lung disease.

Impact of reference equations on lung function and outcomes in fibrotic interstitial lung disease.

Journal: ERJ open research

Published: January 13, 2025

Showing 1-12 of 64

Last Updated: 09/26/2026